TP73 and non-small cell lung carcinoma: In conclusion, the data of this study indicate that plasma TP73‐AS1 and CRNDE levels could be applied for discriminating NSCLC from healthy controls or BLD and could be potentially used to diagnose early‐stage NSCLC.